|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Products | |||||
| Services and Other | |||||
| Total net revenue | |||||
| Costs and expenses: | |||||
| Cost of revenue | |||||
| Products | |||||
| Services and Other | |||||
| Total cost of revenue | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total costs and expenses | |||||
| Income from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Income before taxes, as reported | |||||
| Provision for income taxes | |||||
| Net Income | |||||
| Net income per share: | |||||
| Net income per share - basic | |||||
| Net income per share - diluted | |||||
| Weighted Averge Shares Used In Computing Net Income Per Share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...